Cargando…
Contemporary RNA Therapeutics for Glioblastoma
Glioblastoma (GBM) is the most common primary brain tumor in adults and is universally lethal with a median survival of less than two years with standard therapy. RNA-based immunotherapies have significant potential to establish a durable treatment response for malignant brain tumors including GBM....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186014/ https://www.ncbi.nlm.nih.gov/pubmed/34101090 http://dx.doi.org/10.1007/s12017-021-08669-9 |